4.7 Article

Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 154, Issue -, Pages 172-178

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2020.09.024

Keywords

Radiotherapy; Rectal cancer; Magnetic resonance imaging; Image-guided radiation; Neoadjuvant therapy

Ask authors/readers for more resources

This study evaluates the feasibility and implementation of MR-guided radiotherapy for rectal cancer on a 1.5T MR-linac. Results show that daily online adaptation of the CTV can reduce margins effectively and achieve good treatment outcomes. The treatment process takes about 48 minutes per fraction.
Background and purpose: Daily online adaptation of the clinical target volume (CTV) using MR-guided radiotherapy enables margin reduction of the planning target volume (PTV). This study describes the implementation and initial experience of MR-guided radiotherapy on the 1.5T MR-linac and evaluates treatment time, patient compliance, and target coverage, including an initial assessment of margin reduction. Materials and methods: Patients were treated on a 1.5T MR-linac (7MV, FFF). At each fraction a 3D T2 weighted (T2w) MR-sequence was acquired on which the CTV was adapted after a deformable registration of the contours from the pre-planning CT scan. Based on the new contours a full online replanning was done after which a new 3D T2w MR-sequence was acquired for position verification. A 5 field Intensity Modulated Radiotherapy (IMRT) plan was delivered. Results: Forty-three patients with rectal cancer were treated with 25 Gy in 5 fractions of which 18 with reduced margins. In total, 204 of 215 fractions were delivered on the MR-linac all of which obtained a clinically acceptable treatment plan. Median in-room time per fraction was 48 min (interquartile range 8). No fractions were canceled or interrupted because of patient intolerance. CTV coverage after margin reduction was good on all post-treatment scans but one due to passing gas. Conclusion: MR-guided radiotherapy using daily full online recontouring and replanning on a 1.5T MR-linac for rectal cancer is feasible and currently takes about 48 min per fraction. (C) 2021 The Authors. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

MRI commissioning of 1.5T MR-linac systems - a multi-institutional study

Rob H. N. Tijssen, Marielle E. P. Philippens, Eric S. Paulson, Markus Glitzner, Brige Chugh, Andreas Wetscherek, Michael Dubec, Jihong Wang, Uulke A. van der Heide

RADIOTHERAPY AND ONCOLOGY (2019)

Article Oncology

Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator

Ernst S. Kooreman, Petra J. van Houdt, Marlies E. Nowee, Vivian W. J. van Pelt, Rob H. N. Tijssen, Eric S. Paulson, Oliver J. Gurney-Champion, Jihong Wang, Folkert Koetsveld, Laurens D. van Buuren, Leon C. ter Beek, Uulke A. van der Heide

RADIOTHERAPY AND ONCOLOGY (2019)

Article Oncology

Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics

Philippe Bulens, Alice Couwenberg, Martijn Intven, Annelies Debucquoy, Vincent Vandecaveye, Eric Van Cutsem, Andre D'Hoore, Albert Wolthuis, Pritam Mukherjee, Olivier Gevaert, Karin Haustermans

RADIOTHERAPY AND ONCOLOGY (2020)

Article Engineering, Biomedical

Improving the imaging performance of the 1.5 T MR-linac using a flexible, 32-channel, on-body receive array

Stefan Emiel Zijlema, Rob H. N. Tijssen, Luca van Dijk, Sara L. Hackett, Jochem W. H. Wolthaus, Wico Breimer, Jan J. W. Lagendijk, Cornelis A. T. Van den Berg

PHYSICS IN MEDICINE AND BIOLOGY (2020)

Article Engineering, Biomedical

Technical feasibility of magnetic resonance fingerprinting on a 1.5T MRI-linac

T. Bruijnen, O. van der Heide, M. P. W. Intven, S. Mook, J. J. W. Lagendijk, C. A. T. van den Berg, R. H. N. Tijssen

PHYSICS IN MEDICINE AND BIOLOGY (2020)

Article Oncology

ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium

Ernst S. Kooreman, Petra J. van Houdt, Rick Keesman, Floris J. Pos, Vivian W. J. van Pelt, Marlies E. Nowee, Andreas Wetscherek, Rob H. N. Tijssen, Marielle E. P. Philippens, Daniela Thorwarth, Jihong Wang, Amita Shukla-Dave, William A. Hall, Eric S. Paulson, Uulke A. van der Heide

RADIOTHERAPY AND ONCOLOGY (2020)

Article Oncology

Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases

Anita M. Werensteijn-Honingh, Ina M. Jurgenliemk-Schulz, Christa G. Gadellaa-Van Hooijdonk, Gonda G. Sikkes, Nicole G. P. M. Vissers, Dennis Winkel, Wietse S. C. Eppinga, Martijn Intven, Bas W. Raaymakers, Petra S. Kroon

Summary: The study found that the use of a vacuum cushion significantly reduced the anterior-posterior translations in target and bony anatomy during pelvic/para-aortic lymph node SBRT, but did not reduce intrafraction motion during the actual radiotherapy delivery. Vacuum cushion immobilization was effective in reducing posterior motion within the first 16 minutes of each treatment session for single targets.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases

Anita M. Werensteijn-Honingh, Anne F. J. Wevers, Max Peters, Petra S. Kroon, Martijn Intven, Wietse S. C. Eppinga, Ina M. Jurgenliemk-Schulz

Summary: Treatment with SBRT for prostate cancer patients with oligometastatic lymph nodes detected on PSMA-PET/CT achieved a median PFS of 16 months. Higher pre-SBRT PSA, younger age, and extrapelvic location were identified as predictors of shorter PFS.

ACTA ONCOLOGICA (2021)

Article Engineering, Biomedical

Minimizing the need for coil attenuation correction in integrated PET/MRI at 1.5 T using low-density MR-linac receive arrays

Stefan E. Zijlema, Woutjan Branderhorst, Remco Bastiaannet, Rob H. N. Tijssen, Jan J. W. Lagendijk, Cornelis A. T. van den Berg

Summary: This study investigated the use of 1.5 T MR-linac (MRL) receive arrays for PET/MRI, and evaluated their impact on PET sensitivity and image reconstructions. Results showed that MRL arrays can significantly reduce PET signal losses, with the prototype MRL array allowing flexible positioning without compromising PET or MRI performance.

PHYSICS IN MEDICINE AND BIOLOGY (2021)

Article Engineering, Biomedical

A mask-compatible, radiolucent, 8-channel head and neck receive array for MRI-guided radiotherapy treatments and pre-treatment simulation

Stefan E. Zijlema, Wico Breimer, Mark W. J. M. Gosselink, Tom Bruijnen, Catalina S. Arteaga de Castro, Rob H. N. Tijssen, Jan J. W. Lagendijk, Marielle E. P. Philippens, Cornelis A. T. van den Berg

Summary: By developing a mask-compatible 8-channel head and neck array, we improved the imaging performance of MRI-simulation and MR-linac acquisitions, while inducing no clinically significant dose changes.

PHYSICS IN MEDICINE AND BIOLOGY (2022)

Article Oncology

Feasibility of online radial magnetic resonance imaging for adaptive radiotherapy of pancreatic tumors

Guus Grimbergen, Hidde Eijkelenkamp, Jonna K. van Vulpen, Saskia van de Ven, Bas W. Raaymakers, Martijn P. W. Intven, Gert J. Meijer

Summary: This study investigated the use of two motion-robust radial MRI sequences for pancreatic MR-guided radiotherapy. It found that PROPELLER MRI may be a superior imaging sequence for pancreatic MRgRT, but further optimization is needed to reduce large interslice variation.

PHYSICS & IMAGING IN RADIATION ONCOLOGY (2023)

Article Engineering, Biomedical

A dual-purpose MRI acquisition to combine 4D-MRI and dynamic contrast-enhanced imaging for abdominal radiotherapy planning

Bjorn Stemken, Fieke M. Prins, Tom Bruijnen, Linda G. W. Kerkmeijer, Jan J. W. Lagendijk, Cornelis A. T. van den Ber, Rob H. N. Tijssen

PHYSICS IN MEDICINE AND BIOLOGY (2019)

Article Oncology

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala

Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn

Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang

Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research

Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai

Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner

Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma

Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia

Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2024)

Review Oncology

Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review

Xiaoyong Xiang, Zhe Ji, Jing Jin

Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques

Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman

Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy

Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost

Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity

Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni

Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

The rise of negative portrayals of radiation oncology: A textual analysis of media news

Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka

Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)

Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes

Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.

RADIOTHERAPY AND ONCOLOGY (2024)